Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APE1-guided Endostar plus FOLFOX in advanced colorectal cancer
ChiCTR1800014879Phase 4Not yet recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of endostar in colorectal cancer (CRC) (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: progression-free survival and objective response rate. Planned start Mar 2018; status: not yet recruiting.
02
Drugs
endostar
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR1800014879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014879.